 |
|
|
|
 |
|
|
| Article 1 to 10 out of 17 concerning Beckman Coulter, Inc.
|
-
Phenomenex to Distribute Beckman Coulter's IgY Proteome Enrichment Chemistry for Biomarker Discovery
(11 Jun 2007)
Phenomenex Inc. announced a distribution agreement for Beckman Coulter's ProteomeLab IgY enrichment products for proteomics and biomarker discovery. The agreement grants Phenomenex exclusive distribution rights in the United States, Canada and ...
-
Beckman Coulter Announces Additional Details on Financing for Its Proposed Acquisition of Biosite Incorporated
(17 Apr 2007)
Beckman Coulter, Inc. announced additional details regarding its financing strategy for the proposed acquisition of Biosite Incorporated. On March 25, 2007, Beckman Coulter announced it had entered into a definitive merger agreement with Biosite ...
-
Biosite Prepared to Enter Into Discussions With Inverness Medical Innovations
(12 Apr 2007)
Biosite Incorporated announced that its Board of Directors, after consultation with its financial and legal advisors, has determined that the acquisition proposal set forth in the letter received from Inverness Medical Innovations, Inc. on April 4, ...
-
Cornell researcher works to develop cheap, quick health test for people with HIV/AIDS in developing countries
(28 Mar 2007)
A Cornell researcher is working to develop a quick, simple and cheap immune-system test for people in the developing world. It could help HIV/AIDS sufferers in the poorest countries get appropriate treatment to extend their lives, possibly by as ...
-
Beckman Coulter to Acquire Biosite Incorporated
(27 Mar 2007)
Beckman Coulter, Inc. and Biosite(R) Incorporated announced that they have entered into a definitive merger agreement under which Beckman Coulter will acquire all of Biosite's outstanding common stock in a cash tender offer of $85.00 per share, or ...
-
Agencourt Genomic Services Collaborates in New Study on Breast and Colon Cancer Genes
(26 Sep 2006)
Agencourt Bioscience Corporation, a Beckman Coulter company, has announced that its Genomic Services were integral in a breakthrough Johns Hopkins study on the genetic code for breast and colon cancers. A recent report on that study, published this ...
-
Beckman Coulter Licenses Roche`s Real Time PCR Patent Portfolio
(24 Jul 2006)
Beckman Coulter, Inc. has acquired an In Vitro Diagnostics product license to all real-time polymerase chain reaction (PCR) patents and pending patent applications owned or controlled by Roche Diagnostics, a division of F. Hoffmann-La Roche Ltd, ...
-
Applera and Beckman Coulter Announce Final Agreement on Settlement
(06 Jul 2006)
Outstanding Legal Disputes Resolved
Applera Corporation and Beckman Coulter, Inc. jointly announced that they have entered into a definitive agreement to resolve all outstanding legal disputes between the parties regarding claims to certain Beckman Coulter patented capillary ...
-
Applera and Beckman Coulter Announce Terms of Settlement of Legal Disputes regarding PCR technology
(28 Apr 2006)
Applera Corporation and Beckman Coulter, Inc. jointly announced that they have established the terms of a settlement to resolve all outstanding legal disputes between the parties regarding claims to certain Beckman Coulter patented capillary ...
-
New CD85d (ILT4)-PE RUO Monoclonal Antibody Identifies Tolerogenic Cells
(06 Apr 2006)
Beckman Coulter introduces IOTest® CD85d-(ILT4)-PE conjugated monoclonal antibody. ILT4 is selectively expressed on myelomonocytic cells and binds to classical and nonclassical human leucocyte antigen (HLA) class I molecules. ILT4 is believed to ...
|
|
|
|
|
Top
